Delivery Order SPE2DR25D1100-SPE2DR26FDB3B
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,210.66 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 MG tablets (100-count units) under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and does not utilize a set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under...
- The Defense Logistics Agency awarded a delivery order valued at $9,201.03 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by November 4, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with a ceiling value of $1,229.86. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.49 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on December 5, 2025, with completion targeted for December 8, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Glimepiride 4 mg tablets (100 count) with a ceiling value of $2,377.11. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is set for ultimate completion by July 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,966.26 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on January 12, 2026, will be completed by January 13, 2026, and represents a small but essential pharmaceutical procurement for federal medical supply needs. The contract carries no set-aside designation, indicating it was awarded through full and open competition....
- The Defense Logistics Agency awarded a delivery order valued at $2,950.40 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitive, non-set-aside award reflects a firm fixed-price contract type and represents a routine pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The contract is executed as a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $5,259.83 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,065.08 to AmerisourceBergen Drug Corp for the supply of Glimepiride 1 mg tablets in quantities of 100 units. This firm fixed-price contract was competitively awarded without set-aside provisions and is scheduled for completion by December 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FDB3BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,871.86 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count bottles) on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., and operates from its corporate headquarters in Conshohocken, Pennsylvania, where the pharmaceutical product will be delivered. This delivery order is executed under Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (valued at up to $999,999,999.00 through December 31, 2031), which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally. The IDC enables DLA to procure a broad spectrum of pharmaceutical products, including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. AmerisourceBergen's position as a major pharmaceutical distributor and established federal contractor demonstrates its capability to meet critical medical supply requirements for military treatment facilities and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/22/26 |